To determine if the reduced tumour burden was accompanied by increases in T-cell and DC-infiltrates following CCL19 therapy, flow cytometric analyses was performed on percol purified leucocyte populations of tumour nodules. This evidence concerns the gene CCL19 and neoplasm.